Zurueck zur Suche

Reporte zur Charge UT7731JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 MA 1

VAERS 2598689

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731JA

mild
Staat
MA
Alter
0,6
Geschlecht
F
Eingang
17.03.2023
Impfdatum
17.03.2023
Beginn
17.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

Pt's mother alerted RN approximately 3 minutes after administration that hives began developing on right thigh. MD notified, hives observed to chest and back, no visible respiratory distress noted, o2 sat 100%. Continued monitoring in office, hives appeared to be resolving. Pt remained in office until 4:00 with multiple checks to assess pt by RN and MD. Pt left office with advice to call office if hives return, any s/s of respiratory distress, or other symptom develops.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
-
Andere Medikamente
-
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2646581

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731JA

gering
Staat
TX
Alter
1,4
Geschlecht
F
Eingang
17.06.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

early dose administered of FLUZONE QIV NP to a pediatric patient/ medical assistants inadvertently missed the dosing interval time was earlier than recommended,with no reported adverse event; Initial information received on 13-Jun-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 17 months old female patient who had early dose administered of fluzone qiv np to a pediatric patient/ medical assistants inadvertently missed the dosing interval time was earlier than recommended,with no reported adverse event after receiving vaccine influenza quadrival a-b vaccine [fluzone qiv]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Jun-2023, the patient received a dose 3 0.5 ml of suspect influenza quadrival a-b vaccine Suspension for injection lot UT7731JA, 30-JUN-2023 via intramuscular route in the left thigh for immunisation. On 13-Jun-2023 the patient developed a non-serious early dose administered of fluzone qiv np to a pediatric patient/ medical assistants inadvertently missed the dosing interval time was earlier than recommended,with no reported adverse event (inappropriate schedule of product administration) (latency: same day). Action taken was not applicable. Outcome: Unknown for the event early dose administered of fluzone qiv np to a pediatric patient/ medical assistants inadvertently missed the dosing interval time was earlier than recommended,with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644664

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731JA

gering
Staat
TX
Alter
1,4
Geschlecht
F
Eingang
13.06.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient was administered a third dose of the Fluzone Quadrivalent no adverse reaction was reported or noted at the time of administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-